Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
Fundraising walks remain important in Alzheimer’s advocacy because they serve as the primary mechanism connecting community participation directly to research funding and care support—without them, critical programs that help the 7.4 million Americans age 65 and older currently living with Alzheimer’s disease would lose substantial resources. The Walk to End Alzheimer’s, held across more than 600 communities nationwide, is the world’s largest event dedicated to Alzheimer’s awareness and fundraising, demonstrating that these events have evolved beyond symbolic gestures to become essential funding engines for a disease that affects approximately 1 in 9 older Americans. Consider the tangible reality: Hawaii’s 2025 Walk raised more than $1 million for local Alzheimer’s Association programs, while St.
Cloud’s event brought in nearly $112,000 and Aiken’s raised $70,375. These aren’t abstract numbers—they represent community members saying they believe this disease matters enough to invest their time and resources. When you understand that nearly two-thirds of Americans with Alzheimer’s are women, and that 1 in 3 older adults will die with Alzheimer’s or another dementia, the urgency of maintaining and expanding these fundraising efforts becomes clear.
Table of Contents
- Understanding the Scale of Alzheimer’s and the Funding Crisis
- The Financial Burden That Keeps Growing
- From Local Walks to National Research Momentum
- How Walk Funds Transform Lives in Local Communities
- Why Individual Advocacy Must Continue Despite Large-Scale Challenges
- The Critical Role of Awareness in Early Detection
- The Future of Community-Driven Alzheimer’s Advocacy
- Conclusion
- Frequently Asked Questions
Understanding the Scale of Alzheimer’s and the Funding Crisis
The prevalence of Alzheimer’s disease in America is staggering, yet remains somewhat invisible in mainstream conversation. Seven point four million Americans over age 65 are currently living with Alzheimer’s—a number that continues to grow as the population ages. To put this in perspective, that’s roughly 1 in 9 older adults. The gender disparity is particularly striking: nearly two-thirds of people with Alzheimer’s are women, which has significant implications for families and caregiving patterns. The mortality data adds another layer of urgency. One in three older adults dies with Alzheimer’s or another form of dementia, according to the Alzheimer’s Association.
This isn’t a rare disease that primarily affects a small subset of the population; it’s a widespread condition reshaping how we think about aging, family structure, and end-of-life care. Without sustained funding for research, treatment development, and community support services, these numbers will only grow. This scale is why grassroots fundraising through community events remains irreplaceable. Federal funding, while important, cannot meet the full scope of need. The Alzheimer’s Association alone is investing more than $490 million in over 1,220 active research projects across six continents, but that’s a fraction of what would be needed if we were to effectively combat this disease. Fundraising walks create a bridge between the person who has experienced Alzheimer’s in their family and the researchers working to understand and eventually prevent it.
The Financial Burden That Keeps Growing
The cost of Alzheimer’s disease extends far beyond what most people realize. Health and long-term care costs for people with Alzheimer’s and other dementias are projected to reach $409 billion in 2026, with Medicare and Medicaid covering $263 billion (64% of the total) and families bearing $103 billion out of pocket. This means the disease doesn’t just take a cognitive and emotional toll—it creates catastrophic financial consequences for families. Looking forward, the trajectory is alarming. By 2050, costs are projected to reach nearly $1 trillion annually if current trends continue and no disease-modifying breakthroughs occur. That projection assumes no improvement in treatments and no decrease in incidence, but it illustrates why early action on prevention and treatment research matters now.
One limitation of focusing solely on federal funding is that government budgets are finite and subject to competing priorities. Congress did approve a $100 million increase for Alzheimer’s and dementia research at the NIH in FY 2026—bringing total annual federal dementia research funding to $3.9 billion—and the CDC received $41.5 million to implement the BOLD Infrastructure for Alzheimer’s Act. While these are meaningful increases, they still fall short of matching the scale of the disease’s impact. This is where local fundraising walks become critical. They mobilize private funding that supplements government research dollars and ensures that care infrastructure, support services, and community programs can continue operating even when federal budgets face constraints. Every dollar raised at a local walk translates directly to programs in that community that wouldn’t exist otherwise.
From Local Walks to National Research Momentum
The relationship between grassroots fundraising and research progress is direct and measurable. The Alzheimer’s Association’s investment of more than $490 million in over 1,220 research projects worldwide demonstrates the scale of what organized funding can accomplish. These aren’t speculative investments—they represent peer-reviewed research aimed at understanding disease mechanisms, developing treatments, and identifying prevention strategies. Many of these projects would not exist without the funding pipeline created by events like the Walk to End Alzheimer’s. Research funding through the Alzheimer’s Association has led to meaningful advances in early detection and the emergence of disease-modifying treatments.
New medications that can slow disease progression have recently become available, but here’s the critical limitation: they only work in the earliest stages of Alzheimer’s disease. This makes early diagnosis and awareness absolutely essential. You cannot benefit from a treatment if you don’t know you have the disease, which is why the awareness component of fundraising walks—bringing the disease into community consciousness—is as important as the money raised. The $100 million congressional increase in NIH funding and the $41.5 million for BOLD Infrastructure represent important validation that Alzheimer’s research deserves national priority. However, these government funds are designed to support long-term research infrastructure and prevention work, not the immediate support services that people with Alzheimer’s and their families need right now. That’s where community-raised funds fill a critical gap.
How Walk Funds Transform Lives in Local Communities
The practical impact of walk fundraising extends into specific, measurable community services. Funds raised through Walk to End Alzheimer’s support free local education programs that help people understand early warning signs, caregiver support groups that provide both emotional and practical assistance, respite services that give exhausted family members essential breaks, access to a 24/7 helpline for people in crisis, and one-on-one care consultations. For many families, these services represent the difference between managing Alzheimer’s at home with support and experiencing crisis-driven transitions to institutional care. St. Cloud’s walk that raised nearly $112,000 in 2025 represents a specific example of community commitment translating to local impact. In a community that size, that funding level makes possible a meaningful suite of services throughout the year. Someone newly diagnosed with mild cognitive impairment can attend free education programs.
A spouse experiencing caregiver burnout can access a support group. A family struggling with behavioral changes can connect with specialists through care consultations. These services prevent crises and reduce the overall cost of care. The limitation here is important to acknowledge: local fundraising is subject to economic fluctuations and community engagement levels. In years when economic conditions are poor, giving often decreases. In communities with smaller populations or lower wealth levels, fundraising may not generate enough resources to sustain comprehensive programming. This is why the Alzheimer’s Association’s broader network and pooling of resources across hundreds of communities helps ensure that no community is left entirely without support.
Why Fundraising Must Continue Despite Large-Scale Challenges
One of the warnings that often goes unspoken is that even spectacular local fundraising efforts cannot, by themselves, solve the Alzheimer’s crisis. Individual walks are critical, but they operate within a larger context of systemic challenges that require policy-level solutions. The projected cost of $1 trillion by 2050 far exceeds what grassroots fundraising can address—it requires breakthroughs in research, changes to long-term care policy, and sustained federal investment. This doesn’t diminish the importance of walks; rather, it clarifies their role. Walks serve multiple functions simultaneously: they raise immediate funds for critical services, they create community awareness that drives early detection, they build political momentum for continued research funding, and they provide emotional validation for people affected by the disease.
However, they cannot replace the need for systemic policy changes around long-term care financing, healthcare access, and research infrastructure. Another limitation is that fundraising walks tend to concentrate in communities with higher population density and greater wealth. Hawaii’s $1 million fundraise reflects both passionate community engagement and the resources available in that state. Meanwhile, rural communities or economically stressed areas may struggle to generate comparable resources despite similar or worse disease burden. This geographic inequality in funding capacity is a real challenge that the field acknowledges but has not yet solved comprehensively.
The Critical Role of Awareness in Early Detection
Beyond the money raised, fundraising walks serve an irreplaceable function in community education and awareness. New treatments that can slow Alzheimer’s disease progression are only available in the earliest stages of the disease, making early diagnosis critically important. Community engagement through events like walks is documented as an important determinant of success in awareness and advocacy efforts. When a walk happens in your community, it signals to everyone around you that Alzheimer’s is a serious public health issue worthy of attention.
A person who might otherwise dismiss memory lapses as normal aging hears at a walk that early cognitive changes should be evaluated by a healthcare provider. A family member recognizes warning signs they hadn’t previously connected to Alzheimer’s. Someone learns about the importance of discussing family history of dementia with their doctor. These awareness functions directly enable the early diagnosis that allows people to access life-altering treatments. Without the visibility created by fundraising events, many people simply don’t get diagnosed until the disease has progressed substantially, at which point treatment options are limited.
The Future of Community-Driven Alzheimer’s Advocacy
As we move forward, the relationship between grassroots fundraising and Alzheimer’s progress will likely intensify rather than diminish. The research momentum generated by over $490 million in Alzheimer’s Association funding is producing a pipeline of potential treatments and prevention strategies. As these advance to clinical use, the need for community programs that help people access early diagnosis, understand treatment options, and navigate complicated healthcare decisions will grow.
The sustainability of fundraising walks will depend partly on maintaining community engagement and partly on continued visibility of research progress. When people see that their fundraising directly enables research that is producing real results—new treatments, better understanding of disease mechanisms, hope for prevention—they remain motivated to participate. The challenge ahead is ensuring that this cycle continues, that research progress is communicated back to fundraising communities, and that the momentum created by walks translates into broader policy support for Alzheimer’s as a national health priority.
Conclusion
Fundraising walks remain important in Alzheimer’s advocacy precisely because they fill multiple roles that no other mechanism quite addresses. They raise essential funding for community services that help people live better with the disease, they create awareness that drives early diagnosis and treatment access, they build community solidarity around a serious health issue, and they generate political momentum for continued research funding. With 7.4 million Americans currently living with Alzheimer’s and costs projected to exceed $1 trillion by 2050, these grassroots efforts are not optional additions to the response—they are essential infrastructure.
If you haven’t yet participated in a Walk to End Alzheimer’s or contributed to one in your community, now is the time. Whether you walk, donate, volunteer, or simply spread awareness, you’re contributing to a system that sustains research, supports families, and maintains hope that we can eventually prevent and treat this disease effectively. The work continues in more than 600 communities nationwide—and your community likely needs you.
Frequently Asked Questions
Why is early diagnosis so important if we only recently got treatments?
New disease-modifying treatments for Alzheimer’s only work in the earliest stages of cognitive decline. If someone isn’t diagnosed until they’re experiencing significant memory loss, these treatments are no longer effective. This makes early diagnosis through community education and awareness literally life-changing for people with the disease.
Does all the money raised at local walks stay in my community?
Walk to End Alzheimer’s funds support programs in the community where the walk takes place, but the Alzheimer’s Association also pools resources nationally to support research, education, and advocacy work that benefits everyone. Individual walks create immediate local impact while also contributing to larger-scale efforts.
How much of fundraising actually goes to research versus overhead and administration?
The Alzheimer’s Association reports that the majority of funds go directly to programs and research. You can verify this through their annual financial reports and watchdog organizations like Charity Navigator that rate nonprofit effectiveness.
If Congress is funding Alzheimer’s research, why do we need community fundraising?
Federal funding is essential but finite. It typically supports long-term research infrastructure and prevention work. Community fundraising fills the gap by funding immediate support services, education programs, and additional research that federal budgets don’t fully cover.
What should I do if I suspect someone has Alzheimer’s?
Encourage them to see their primary care physician, who can conduct initial cognitive screening and refer to a neurologist or dementia specialist for more comprehensive evaluation if needed. The Alzheimer’s Association’s 24/7 helpline can also provide guidance on next steps.
How can I stay involved in Alzheimer’s advocacy year-round?
Beyond the annual walk, you can participate in advocacy campaigns, volunteer with local chapters, attend support groups (even if you’re not directly affected), donate, and raise awareness in your professional and social circles.
You Might Also Like
- Could Alzheimer’s Walks Help Families Feel Less Alone?
- Why Scientists Are Mapping Immune Cells in Alzheimer’s Brains
- Why Lab-Grown Brain Models Matter for Alzheimer’s Research
Related reading
- can Home Care for Alzheimer’s Become Too Much
- why Caregiver Burnout Often Builds Slowly
- what Dementia Families Need Before a Crisis Happens
- how Alzheimer’s Care Promises Can Become Emotionally Complicated
- why Long-Term Care Decisions Are So Painful
For more on this topic, see NIH MedlinePlus — cognitive testing.
